We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Extracellular Collagen Modulates Tumor Progression and Metastasis

By LabMedica International staff writers
Posted on 05 Dec 2017
Print article
Image: Breast cancer cells were grown in a highly dense three-dimensional collagen matrix. After seven days the cells formed networks that resembled the early stages of blood vessel development. This photomicrograph shows representative structures observed in these environments after staining for cell nuclei (blue) and cytoskeletons (green) (Photo courtesy of the University of California, San Diego).
Image: Breast cancer cells were grown in a highly dense three-dimensional collagen matrix. After seven days the cells formed networks that resembled the early stages of blood vessel development. This photomicrograph shows representative structures observed in these environments after staining for cell nuclei (blue) and cytoskeletons (green) (Photo courtesy of the University of California, San Diego).
A recent paper detailed how factors in the tumor microenvironment induce the cancer to progress and metastasize.

Previous studies had suggested that the topographical organization of collagen within the tumor microenvironment modulated cancer cell migration and was independently predictive of progression to metastasis.

Investigators at the University of California, San Diego (USA) explored the relationships between collagen density, collagen architecture, cell migration behavior, gene expression, and metastatic potential. To do this, they developed a three-dimensional collagen matrix model system designed to probe the physical basis of cancer cell migration responses to collagen matrix organization.

Results published in the November 21, 2017, online edition of the journal Nature Communications revealed that collagen matrices with small pores and short fibers conserved a transcriptional response and subsequent motility switch in cancer cells resulting in the formation of multicellular network structures. The response was not mediated by hypoxia, matrix stiffness, or bulk matrix density, but rather by matrix architecture-induced beta1-integrin upregulation. The set of genes, or gene module, which caused this behavior, was dubbed the collagen-induced network phenotype (CINP).

The investigators found that this CINP-induced behavior was consistent with phenotypic and molecular features of clinical vasculogenic mimicry (VM) – the formation of structures resembling blood vessels. Furthermore, they showed that the associated transcriptional response was conserved among cancer types in vitro and was predictive of patient survival in multiple clinical datasets for various tumor types. These findings linked a collagen-induced migration program to VM and suggested that this process could be broadly relevant to metastatic progression in solid human cancers.

"It is almost like the matrix is encoding the gene module," explained senior author Dr. Stephanie Fraley, professor of bioengineering at the University of California, San Diego. "The cells do not exhibit this behavior in traditional petri dishes. It is critical to have the cells surrounded by a three-dimensional environment that mimics what happens in the human body."

Related Links:
University of California, San Diego

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Gold Member
Troponin T QC
Troponin T Quality Control
New
Refrigerated Centrifuge
CAPPRondo Refrigerated Centrifuge
New
Ureaplasma Urealyticum Test
Duplicα RealTime Ureaplasma Urealyticum Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: The discovery of biomarkers could improve endometrial cancer treatment (Photo courtesy of Mount Sinai)

Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer

Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.